Logo image of BRBR

BELLRING BRANDS INC (BRBR) Stock Fundamental Analysis

NYSE:BRBR - New York Stock Exchange, Inc. - US07831C1036 - Common Stock

75.86  +3.47 (+4.79%)

After market: 75.86 0 (0%)

Fundamental Rating

6

BRBR gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 37 industry peers in the Personal Care Products industry. BRBR scores excellent points on both the profitability and health parts. This is a solid base for a good stock. BRBR is valied quite expensively at the moment, while it does show a decent growth rate. With these ratings, BRBR could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

BRBR had positive earnings in the past year.
In the past year BRBR had a positive cash flow from operations.
Each year in the past 5 years BRBR has been profitable.
BRBR had a positive operating cash flow in each of the past 5 years.
BRBR Yearly Net Income VS EBIT VS OCF VS FCFBRBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

Looking at the Return On Assets, with a value of 29.45%, BRBR belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Invested Capital value of 45.89%, BRBR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BRBR is significantly above the industry average of 13.52%.
The 3 year average ROIC (38.65%) for BRBR is below the current ROIC(45.89%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 29.45%
ROE N/A
ROIC 45.89%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
BRBR Yearly ROA, ROE, ROICBRBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

BRBR has a better Profit Margin (12.35%) than 91.67% of its industry peers.
BRBR's Profit Margin has declined in the last couple of years.
BRBR has a better Operating Margin (19.42%) than 91.67% of its industry peers.
In the last couple of years the Operating Margin of BRBR has remained more or less at the same level.
With a Gross Margin value of 35.43%, BRBR is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of BRBR has remained more or less at the same level.
Industry RankSector Rank
OM 19.42%
PM (TTM) 12.35%
GM 35.43%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
BRBR Yearly Profit, Operating, Gross MarginsBRBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

More info and screens

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BRBR is creating value.
BRBR has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, BRBR has more shares outstanding
BRBR has a better debt/assets ratio than last year.
BRBR Yearly Shares OutstandingBRBR Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BRBR Yearly Total Debt VS Total AssetsBRBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 10.19 indicates that BRBR is not in any danger for bankruptcy at the moment.
BRBR has a Altman-Z score of 10.19. This is amongst the best in the industry. BRBR outperforms 88.89% of its industry peers.
BRBR has a debt to FCF ratio of 4.21. This is a neutral value as BRBR would need 4.21 years to pay back of all of its debts.
BRBR's Debt to FCF ratio of 4.21 is fine compared to the rest of the industry. BRBR outperforms 69.44% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.21
Altman-Z 10.19
ROIC/WACC5.14
WACC8.93%
BRBR Yearly LT Debt VS Equity VS FCFBRBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

2.3 Liquidity

A Current Ratio of 2.91 indicates that BRBR has no problem at all paying its short term obligations.
BRBR has a better Current ratio (2.91) than 77.78% of its industry peers.
A Quick Ratio of 1.51 indicates that BRBR should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.51, BRBR is doing good in the industry, outperforming 61.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.91
Quick Ratio 1.51
BRBR Yearly Current Assets VS Current LiabilitesBRBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 46.21% over the past year.
BRBR shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -12.29% yearly.
Looking at the last year, BRBR shows a quite strong growth in Revenue. The Revenue has grown by 19.76% in the last year.
The Revenue has been growing by 18.50% on average over the past years. This is quite good.
EPS 1Y (TTM)46.21%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%24.39%
Revenue 1Y (TTM)19.76%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%17.6%

3.2 Future

Based on estimates for the next years, BRBR will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.17% on average per year.
The Revenue is expected to grow by 10.03% on average over the next years. This is quite good.
EPS Next Y15.18%
EPS Next 2Y15.29%
EPS Next 3Y15.68%
EPS Next 5Y14.17%
Revenue Next Year15.56%
Revenue Next 2Y13.22%
Revenue Next 3Y12.47%
Revenue Next 5Y10.03%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
BRBR Yearly Revenue VS EstimatesBRBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
BRBR Yearly EPS VS EstimatesBRBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 39.31, which means the current valuation is very expensive for BRBR.
The rest of the industry has a similar Price/Earnings ratio as BRBR.
BRBR is valuated rather expensively when we compare the Price/Earnings ratio to 28.29, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 34.13, the valuation of BRBR can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as BRBR.
BRBR is valuated rather expensively when we compare the Price/Forward Earnings ratio to 24.44, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 39.31
Fwd PE 34.13
BRBR Price Earnings VS Forward Price EarningsBRBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

BRBR's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as BRBR.
Industry RankSector Rank
P/FCF 49.47
EV/EBITDA 24.86
BRBR Per share dataBRBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of BRBR may justify a higher PE ratio.
BRBR's earnings are expected to grow with 15.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.59
PEG (5Y)N/A
EPS Next 2Y15.29%
EPS Next 3Y15.68%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BRBR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BELLRING BRANDS INC

NYSE:BRBR (1/21/2025, 8:04:01 PM)

After market: 75.86 0 (0%)

75.86

+3.47 (+4.79%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)11-18 2024-11-18/amc
Earnings (Next)02-03 2025-02-03/amc
Inst Owners97.95%
Inst Owner Change0.74%
Ins Owners0.73%
Ins Owner Change1.78%
Market Cap9.78B
Analysts82.86
Price Target83.49 (10.06%)
Short Float %1.25%
Short Ratio1.58
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.75%
Min EPS beat(2)0.44%
Max EPS beat(2)19.07%
EPS beat(4)4
Avg EPS beat(4)14.89%
Min EPS beat(4)0.44%
Max EPS beat(4)31.81%
EPS beat(8)8
Avg EPS beat(8)12.37%
EPS beat(12)12
Avg EPS beat(12)13.45%
EPS beat(16)15
Avg EPS beat(16)13.69%
Revenue beat(2)1
Avg Revenue beat(2)0.67%
Min Revenue beat(2)-0.29%
Max Revenue beat(2)1.64%
Revenue beat(4)3
Avg Revenue beat(4)1.86%
Min Revenue beat(4)-0.29%
Max Revenue beat(4)3.78%
Revenue beat(8)6
Avg Revenue beat(8)1.85%
Revenue beat(12)7
Avg Revenue beat(12)0.12%
Revenue beat(16)10
Avg Revenue beat(16)1.02%
PT rev (1m)2.41%
PT rev (3m)26.99%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.03%
EPS NY rev (1m)0%
EPS NY rev (3m)3.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)10.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.51%
Valuation
Industry RankSector Rank
PE 39.31
Fwd PE 34.13
P/S 4.9
P/FCF 49.47
P/OCF 49.02
P/B N/A
P/tB N/A
EV/EBITDA 24.86
EPS(TTM)1.93
EY2.54%
EPS(NY)2.22
Fwd EY2.93%
FCF(TTM)1.53
FCFY2.02%
OCF(TTM)1.55
OCFY2.04%
SpS15.48
BVpS-1.6
TBVpS-3.21
PEG (NY)2.59
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 29.45%
ROE N/A
ROCE 61.22%
ROIC 45.89%
ROICexc 51.69%
ROICexgc 81.98%
OM 19.42%
PM (TTM) 12.35%
GM 35.43%
FCFM 9.91%
ROA(3y)21.67%
ROA(5y)14.52%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)38.65%
ROIC(5y)33.76%
ROICexc(3y)42.57%
ROICexc(5y)39.59%
ROICexgc(3y)77.99%
ROICexgc(5y)768.49%
ROCE(3y)51.56%
ROCE(5y)45.04%
ROICexcg growth 3Y-71.38%
ROICexcg growth 5Y-2%
ROICexc growth 3Y6.3%
ROICexc growth 5Y16.08%
OM growth 3Y12.97%
OM growth 5Y0.42%
PM growth 3Y77.37%
PM growth 5Y-3.04%
GM growth 3Y4.59%
GM growth 5Y-0.59%
F-Score7
Asset Turnover2.38
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.21
Debt/EBITDA 1.96
Cap/Depr 4.93%
Cap/Sales 0.09%
Interest Coverage 6.51
Cash Conversion 47.05%
Profit Quality 80.24%
Current Ratio 2.91
Quick Ratio 1.51
Altman-Z 10.19
F-Score7
WACC8.93%
ROIC/WACC5.14
Cap/Depr(3y)6.58%
Cap/Depr(5y)6.2%
Cap/Sales(3y)0.11%
Cap/Sales(5y)0.13%
Profit Quality(3y)77.59%
Profit Quality(5y)290.17%
High Growth Momentum
Growth
EPS 1Y (TTM)46.21%
EPS 3Y27.55%
EPS 5Y-12.29%
EPS Q2Q%24.39%
EPS Next Y15.18%
EPS Next 2Y15.29%
EPS Next 3Y15.68%
EPS Next 5Y14.17%
Revenue 1Y (TTM)19.76%
Revenue growth 3Y16.98%
Revenue growth 5Y18.5%
Sales Q2Q%17.6%
Revenue Next Year15.56%
Revenue Next 2Y13.22%
Revenue Next 3Y12.47%
Revenue Next 5Y10.03%
EBIT growth 1Y34.62%
EBIT growth 3Y32.15%
EBIT growth 5Y18.99%
EBIT Next Year21.78%
EBIT Next 3Y15.64%
EBIT Next 5Y12.8%
FCF growth 1Y-7.48%
FCF growth 3Y-4.13%
FCF growth 5Y15.77%
OCF growth 1Y-7.42%
OCF growth 3Y-4.07%
OCF growth 5Y15.22%